Cannabidiol Reduced The Striatal Atrophy Caused 3-nitropropionic Acid In Vivo By Mechanisms Independent Of The Activation Of Cannabinoid, Vanilloid TRPV1 And Adenosine A2A Receptors

Huntington's Disease

Key Findings

CBD provides neuroprotection, which may be relevant to Huntington’s disease.

Information and Links


Link: Cannabidiol Reduced The Striatal Atrophy Caused 3-nitropropionic Acid In Vivo By Mechanisms Independent Of The Activation Of Cannabinoid, Vanilloid TRPV1 And Adenosine A2A Receptors

Year: 2007

DOI: 10.1111/j.1460-9568.2007.05717.x


Ratings

(How Ratings Work)

Huntington's Disease — 2


Possible to probable range of efficacy of cannabis for treatment of Huntington's Disease according to the results found in this study.

Drugs Used

Arachidonyl-2-chloroethylamide (ACEA), a CB1 agonist; HU-308, a CB2 agonist; and cannabidiol (CBD)